[go: up one dir, main page]

WO1997046860A3 - Ameliorations apportees a des systemes de detection et a des procedes de prediction de la courbe de dissolution d'un medicament d'une forme galenique pharmaceutique - Google Patents

Ameliorations apportees a des systemes de detection et a des procedes de prediction de la courbe de dissolution d'un medicament d'une forme galenique pharmaceutique Download PDF

Info

Publication number
WO1997046860A3
WO1997046860A3 PCT/US1997/011791 US9711791W WO9746860A3 WO 1997046860 A3 WO1997046860 A3 WO 1997046860A3 US 9711791 W US9711791 W US 9711791W WO 9746860 A3 WO9746860 A3 WO 9746860A3
Authority
WO
WIPO (PCT)
Prior art keywords
dissolution
drug
dosage form
predicting
pharmaceutical dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1997/011791
Other languages
English (en)
Other versions
WO1997046860A9 (fr
WO1997046860A2 (fr
Inventor
Kurt Roinestad
Frank S Cheng
Philip J Palermo
Kevin Bynum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Priority to CA002257106A priority Critical patent/CA2257106C/fr
Priority to JP1998500947A priority patent/JP3380864B6/ja
Priority to EP97941329A priority patent/EP0938657A4/fr
Priority to AU43262/97A priority patent/AU729814B2/en
Priority to US08/915,785 priority patent/US6174497B1/en
Publication of WO1997046860A2 publication Critical patent/WO1997046860A2/fr
Publication of WO1997046860A3 publication Critical patent/WO1997046860A3/fr
Publication of WO1997046860A9 publication Critical patent/WO1997046860A9/fr
Anticipated expiration legal-status Critical
Priority to US09/707,498 priority patent/US6558957B1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N13/00—Investigating surface or boundary effects, e.g. wetting power; Investigating diffusion effects; Analysing materials by determining surface, boundary, or diffusion effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N13/00—Investigating surface or boundary effects, e.g. wetting power; Investigating diffusion effects; Analysing materials by determining surface, boundary, or diffusion effects
    • G01N2013/006—Dissolution of tablets or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne une amélioration apportée à un système de détection utilisé pour mesurer en continu la libération d'un médicament d'une forme galénique pharmaceutique. Ce système comprend un récipient unique ou plusieurs récipients de dissolution contenant un milieu de dissolution, et un dispositif de mesure servant à détecter la quantité de médicament libéré à un moment donné. Ce système amélioré comprend une tige de mélange et une sonde placée dans la tige de mélange ou à l'extérieur des récipients de dissolution, la sonde pouvant mesurer les caractéristiques de dissolution selon des techniques de spectroscopie aux ultraviolets, aux infrarouges, aux infrarouges proches, à fluorescence, électroniques et Raman. La présente invention concerne également un procédé de prédiction de la courbe de dissolution obtenue par une forme galénique pharmaceutique régulée, ce procédé consistant à prendre des mesures en continu de la dose de médicament libéré d'une forme galénique sur une durée pendant laquelle il est prévu que le médicament se libère, et à calculer le reste de la courbe de dissolution en fonction des valeurs obtenues.
PCT/US1997/011791 1996-06-04 1997-06-04 Ameliorations apportees a des systemes de detection et a des procedes de prediction de la courbe de dissolution d'un medicament d'une forme galenique pharmaceutique Ceased WO1997046860A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CA002257106A CA2257106C (fr) 1996-06-04 1997-06-04 Ameliorations apportees a des systemes de detection et a des procedes de prediction de la courbe de dissolution d'un medicament d'une forme galenique pharmaceutique
JP1998500947A JP3380864B6 (ja) 1996-06-04 1997-06-04 医薬製剤からの薬物の溶解曲線を予測するための検出系および方法における改良
EP97941329A EP0938657A4 (fr) 1996-06-04 1997-06-04 Ameliorations apportees a des systemes de detection et a des procedes de prediction de la courbe de dissolution d'un medicament d'une forme galenique pharmaceutique
AU43262/97A AU729814B2 (en) 1996-06-04 1997-06-04 Improvements in detection systems and methods for predicting the dissolution curve of a drug from a pharmaceutical dosage form
US08/915,785 US6174497B1 (en) 1997-06-04 1997-08-21 Detection systems and methods for predicting the dissolution curve of a drug from a pharmaceutical dosage form
US09/707,498 US6558957B1 (en) 1996-06-04 2000-11-07 Detection systems and methods for predicting the dissolution curve of a drug from a pharmaceutical dosage form

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1894496P 1996-06-04 1996-06-04
US60/018,944 1996-06-04

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US08/915,785 Continuation US6174497B1 (en) 1996-06-04 1997-08-21 Detection systems and methods for predicting the dissolution curve of a drug from a pharmaceutical dosage form

Publications (3)

Publication Number Publication Date
WO1997046860A2 WO1997046860A2 (fr) 1997-12-11
WO1997046860A3 true WO1997046860A3 (fr) 1998-02-19
WO1997046860A9 WO1997046860A9 (fr) 1998-04-23

Family

ID=21790557

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/011791 Ceased WO1997046860A2 (fr) 1996-06-04 1997-06-04 Ameliorations apportees a des systemes de detection et a des procedes de prediction de la courbe de dissolution d'un medicament d'une forme galenique pharmaceutique

Country Status (4)

Country Link
EP (1) EP0938657A4 (fr)
AU (1) AU729814B2 (fr)
CA (1) CA2257106C (fr)
WO (1) WO1997046860A2 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9884025B2 (en) 2000-11-15 2018-02-06 Aptalis Pharma S.R.L. Microspheres of pancreatic enzymes with high stability and production method thereof
US9976171B2 (en) 2011-08-08 2018-05-22 Allergan Pharmaceuticals International Limited Method for dissolution testing of solid compositions containing digestive enzymes
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
US10184121B2 (en) 2013-06-28 2019-01-22 Allergan Pharmaceuticals International Limited Methods for removing viral contaminants from pancreatic extracts
US10993996B2 (en) 2013-08-09 2021-05-04 Allergan Pharmaceuticals International Limited Digestive enzyme composition suitable for enteral administration
US11364205B2 (en) 2010-10-01 2022-06-21 Societe Des Produits Nestle S.A. Stable low digestive enzyme content formulation

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7337500A (en) * 1999-08-30 2001-03-26 Delphian Technology Inc. In situ methods for measuring the release of a substance from a dosage form
SE0000522D0 (sv) * 2000-02-17 2000-02-17 Astrazeneca Ab Mixing apparatus
US7470545B2 (en) * 2001-11-05 2008-12-30 Rohm And Haas Company Buccal dissolution of active substances
ES2560527T3 (es) 2007-02-20 2016-02-19 Allergan Pharmaceuticals International Limited Composiciones estables de enzimas digestivas
FI127992B (fi) * 2014-08-29 2019-07-15 Svanbaeck Sami Menetelmä ja järjestelmä aineen liukenemisominaisuuksien määrittämiseksi
GB2550539A (en) 2016-03-21 2017-11-29 Res Center Pharmaceutical Engineering Gmbh Monitoring dissolution of a dosage form in progress during dissolution by low coherence interferometry
CN117783459B (zh) * 2024-02-28 2024-05-07 沈阳科惠生物医药科技有限公司 一种药物的溶出曲线测定方法及系统

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335438A (en) * 1980-04-17 1982-06-15 Smolen Victor F Method and apparatus for automatic dissolution testing of products
US5133892A (en) * 1990-10-17 1992-07-28 Lever Brothers Company, Division Of Conopco, Inc. Machine dishwashing detergent tablets
US5142920A (en) * 1989-12-20 1992-09-01 Prolabo Dissolution cell and apparatus for determining solids-dissolving kinetics
US5589649A (en) * 1994-02-25 1996-12-31 Distek, Inc. Dissolution testing apparatus

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335438A (en) * 1980-04-17 1982-06-15 Smolen Victor F Method and apparatus for automatic dissolution testing of products
US5142920A (en) * 1989-12-20 1992-09-01 Prolabo Dissolution cell and apparatus for determining solids-dissolving kinetics
US5133892A (en) * 1990-10-17 1992-07-28 Lever Brothers Company, Division Of Conopco, Inc. Machine dishwashing detergent tablets
US5589649A (en) * 1994-02-25 1996-12-31 Distek, Inc. Dissolution testing apparatus

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9884025B2 (en) 2000-11-15 2018-02-06 Aptalis Pharma S.R.L. Microspheres of pancreatic enzymes with high stability and production method thereof
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
US11364205B2 (en) 2010-10-01 2022-06-21 Societe Des Produits Nestle S.A. Stable low digestive enzyme content formulation
US9976171B2 (en) 2011-08-08 2018-05-22 Allergan Pharmaceuticals International Limited Method for dissolution testing of solid compositions containing digestive enzymes
US10184121B2 (en) 2013-06-28 2019-01-22 Allergan Pharmaceuticals International Limited Methods for removing viral contaminants from pancreatic extracts
US10993996B2 (en) 2013-08-09 2021-05-04 Allergan Pharmaceuticals International Limited Digestive enzyme composition suitable for enteral administration

Also Published As

Publication number Publication date
AU729814B2 (en) 2001-02-08
CA2257106A1 (fr) 1997-12-11
EP0938657A2 (fr) 1999-09-01
CA2257106C (fr) 2002-04-23
EP0938657A4 (fr) 1999-10-27
JP3380864B2 (ja) 2003-02-24
WO1997046860A2 (fr) 1997-12-11
JPH11514088A (ja) 1999-11-30
AU4326297A (en) 1998-01-05

Similar Documents

Publication Publication Date Title
WO1997046860A3 (fr) Ameliorations apportees a des systemes de detection et a des procedes de prediction de la courbe de dissolution d'un medicament d'une forme galenique pharmaceutique
WO2005043109A3 (fr) Plates-formes diagnostiques sers, procedes et systemes faisant intervenir des microreseaux, des biocapteurs et des biopuces
CA2332112A1 (fr) Controle d'analytes physiologiques
JPH11242024A5 (fr)
CA2330629A1 (fr) Procede et dispositif permettant de prevoir des valeurs de mesures physiologiques
EP0376133A3 (fr) Méthode et dispositif pour mesurer une substance cible dans un échantillon fluide
EP0153883A3 (fr) Appareil pour l'analyse de gaz
EP0823634A3 (fr) Mesure de la concentration d'un analyte en utilisant un cône tronqué creux
CA2143209A1 (fr) Dispositif d'etalonnage, d'electrodes, par exemple
GB2203249B (en) Apparatus and method for identifying or measuring gas or liquid borne substances
WO2005001462A8 (fr) Systeme et methode destines a detecter un capteur imprecis pendant une mesure d'analyte dans un liquide biologique
EP0823635A3 (fr) Appareil de test d'un réactif en forme de cône tronqué creux
WO2004081498A3 (fr) Indicateurs de niveau de liquide
EP0895747A3 (fr) Dispositif de régulation de pression et procédé de commande de pression appliquée pour un organisme vivant pendant de mesure de données biologiques
EP0895746A3 (fr) Méthode et dispositif de positionnement d'un organism vivant
CA2236636A1 (fr) Methode et dispositif permettant de detecter les ruptures dans les cables de precontrainte
EP0353985A3 (fr) Sonde d'acide nucléique pour la détection de Neisseria gonorrhoea
ZA965271B (en) Flow cell sensor apparatus and optical detection device for analytical measurements on flowable samples and methods of carrying out analytical and optical analytical measurements on flowable samples
WO2004034063A3 (fr) Appareil de detection
IL94672A0 (en) Portable,autonomous apparatus for in situ analysis of liquid or solid substances
NO974000D0 (no) Fremgangsmåte og forbindelser for påvisning av analytter, ved hjelp av remanensmålinger, samt anvendelse av slike forbindelser
EP0801301A3 (fr) Procédé optique pour la détermination de l'acide mévalonique
CA2051885A1 (fr) Appareil pour mesurer les liquides
WO2001040511A3 (fr) Systeme de detection
WO2000055354A3 (fr) Test diagnostique

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
COP Corrected version of pamphlet

Free format text: PAGES 1/12-12/12, DRAWINGS, REPLACED BY NEW PAGES 1/13-13/13; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

ENP Entry into the national phase

Ref document number: 2257106

Country of ref document: CA

Ref country code: CA

Ref document number: 2257106

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 500947

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1997941329

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 1997941329

Country of ref document: EP